Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo
Citation
Li, M., Ye, Z.-W., Tang, K., Guo, L., Bi, W., Zhang, Y., … Dang, B. (2022, April 13). Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo. Cell Research. Springer Science and Business Media LLC. http://doi.org/10.1038/s41422-022-00656-4
Resource Type
Addition Details
Date:
2022-06-01
Wave of COVID:
5th
Category:
Source URL: